Lidocaine Hydrochloride Laboratoire Aguettant (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on neuronal membranes, preventing sodium influx that is essential for depolarisation. By inhibiting the generation and propagation of nerve impulses, lidocaine stops the transmission of pain signals, resulting in a temporary loss of sensation in the area where it is administered.

The specific dose of lidocaine Hydrochloride Laboratoire Aguettant is determined by the prescribing clinician based on the intended use, patient weight, site of administration, and clinical guidelines. Only a qualified healthcare professional should set the dosage and administration schedule.

Safety data for lidocaine Hydrochloride during pregnancy and lactation are limited, and the pregnancy category is listed as unknown. Use should only be considered when the potential benefit justifies any potential risk to the fetus or infant, and it must be prescribed by a qualified practitioner.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials. The team then replies with pricing, availability, shipping details (including cold‑chain if required) and any necessary import documentation.

Lidocaine is a medium‑duration amide‑type local anesthetic with a rapid onset, making it suitable for a wide range of procedures. Compared with shorter‑acting agents like procaine, lidocaine provides longer analgesia, while agents such as bupivacaine offer even longer duration but have a higher risk of cardiotoxicity. Choice depends on the clinical context and safety considerations.

Store lidocaine Hydrochloride Laboratoire Aguettant at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from light and moisture, and ensure the container is tightly sealed to maintain sterility.

Lidocaine Hydrochloride is supplied as a sterile solution for injection and can be administered via epidural, infiltration, intravenous, or subcutaneous routes. The specific technique—such as epidural catheter placement, local infiltration, or intravenous infusion—depends on the intended indication and is performed by a qualified healthcare professional.

The most serious risks include severe allergic reactions (anaphylaxis), cardiac arrhythmias, central nervous system toxicity (seizures, loss of consciousness), methemoglobinemia, and respiratory depression. Prompt recognition and supportive management are essential if any of these events occur.

Lidocaine should be avoided in patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, in those with severe heart block, significant hepatic impairment, or in patients taking medications that markedly increase lidocaine plasma levels without appropriate monitoring.